In interviews with STAT Senior Writer Adam Feuerstein, who recorded the confrontation, Cohodes, and MiMedx CEO Parker "Pete" Petit, it becomes clear they each perceive the event differently.
In a rather uncharacteristic breakout session at the J.P. Morgan Healthcare Conference, short seller Marc Cohodes and MiMedx CEO Parker "Pete" Petit got into an argument over the medical device company's business practices and it was captured on Periscope.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The PAC was operated by Georgia-based MiMedx, whose CEO Parker H. “Pete” Petit is among the top individual contributors to Price. Federal election law prohibits corporations from coercing employees to contribute to PACs.
After MiMedx‘s (MDXG) recent disagreement with the FDA, the company has signed a distribution deal with Medtronic (MDT) for its PURION processed allograft products. Medtronic’s subsidiary SpinalGraft Technologies will promote, market and sell the private-labeled product for spinal applications in the United States. This comes as happy news for the company, which received an Untitled […]